SEC Filing Summary: Nephros, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on August 21, 2006. The filing addresses a material restatement of financial statements for the three months ended March 31, 2006, due to errors in accounting for stock-based compensation.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or debt figures. The primary financial metric disclosed is a correction to a prior period expense:
- Stock-Based Compensation Error: An overstatement of $368,197 in non-cash stock-based compensation expense for the quarter ended March 31, 2006.
- Allocation Error: The expense was not properly allocated between research and development and selling, general, and administrative categories.
Material Changes Versus Prior Period
The material change involves the restatement of the first quarter 2006 financial statements. The previously reported figures are no longer reliable. The corrected figures are reflected in the Company's Second Quarter 10-QSB filed on August 22, 2006. The error arose during the adoption of Statement of Financial Accounting Standards No. 123 (Revised 2004).
Guidance, Outlook, and Risks
Management Commentary and Actions:
- The Company intends to file an amended Quarterly Report on Form 10-QSB/A for the three months ended March 31, 2006, as soon as practicable.
- A press release regarding the restatement was issued on August 22, 2006.
- The Audit Committee has discussed the matter with the independent auditors, Deloitte & Touche LLP.
Risks and Contingencies:
- Internal Control Weakness: The Company identified a material weakness in its internal control over financial reporting related to the stock-based compensation accounting error.
- Remediation: The Company states the weakness is in the process of being remedied.
Investor Verification Checklist
- Verify the corrected financial figures in the Second Quarter 10-QSB filed on August 22, 2006.
- Monitor the filing of the amended Form 10-QSB/A for the quarter ended March 31, 2006.
- Review the Company's progress in remediating the identified material weakness in internal controls.
- Confirm the specific impact of the $368,197 adjustment on net income and earnings per share for the first quarter of 2006.